SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

Share Price is delayed by 15 minutes
Get Live Data
16.00    0.00 (0.00%)
Bid:
15.00
Ask:
17.00
Spread: 2.00 (13.333%)
Market Cap: £17.55m
TEAM Live PriceLast checked at - London Stock Exchange

Intraday Team Share Chart

Scheme becomes Effective

24 Mar 2026 15:00

RNS Number : 9489X
Team PLC
24 March 2026
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

24 March 2026

RECOMMENDED ACQUISITION

OF

W.H. IRELAND GROUP PLC ("WH IRELAND" OR THE "COMPANY")

BY

TEAM PLC ("TEAM")

to be implemented by means of a scheme of arrangementpursuant to Part 26 of the Companies Act 2006

SCHEME BECOMES EFFECTIVE

SUSPENSION OF TRADING

Further to the announcement on 20 March 2026 confirming that the Court had sanctioned the Scheme, the boards of WH Ireland and Team are pleased to announce that the Court Order (together with a copy of the Scheme and any documents required to be annexed thereto) has been delivered to the Registrar of Companies today and accordingly the Scheme has now become Effective in accordance with its terms and WH Ireland is now a wholly owned subsidiary of Team.

Full details of the Acquisition are set out in the Company's scheme document which was published and made available to WH Ireland Shareholders on 10 December 2025 (the "Scheme Document"). Capitalised terms used in this announcement (the "Announcement") shall, unless otherwise defined, have the same meanings as set out in the Scheme Document.

As previously advised, trading in WH Ireland Shares on AIM was suspended with effect from 7.30 a.m. today. An application has been made to the London Stock Exchange in relation to the cancellation of the admission to trading of WH Ireland Shares on AIM, which is expected to take place at 7.00 a.m. on 25 March 2026. As a result of the Scheme having become effective, share certificates in respect of WH Ireland Shares will cease to be valid documents of title and entitlements to WH Ireland Shares held in uncertificated form in CREST are being cancelled.

Under the terms of the Scheme, a Scheme Shareholder on the register of members of WH Ireland at the Scheme Record Time, being 6.00 p.m. on 23 March 2026, will be entitled to receive 0.195 New Team Shares for each Scheme Share held.

Settlement

Settlement of the consideration to which any Scheme Shareholder is entitled will be effected by the crediting of CREST accounts (for WH Ireland Shareholders holding Scheme Shares in uncertificated form) or the issue of certificates in respect of the New Team Shares, as soon as practicable, but in any event by no later than 14 days after the Effective Date (being 7 April 2026).

Resignation of Directors

John Cusins has resigned as a non-executive director of WH Ireland and each of Phillip Wale and Simon Jackson have resigned as directors and ceased to hold any office with WH Ireland or any of its subsidiaries. All such resignations being effective from the effective date of the Scheme.

End of Offer Period

The Company is no longer in an "Offer Period" as defined in the Takeover Code and accordingly the dealing disclosure requirements of the Takeover Code no longer apply.

Enquiries:

Team plc Mark Clubb

+ 44 (0) 1534 877210

H&P Advisory Limited (financial adviser to Team) Neil Passmore / Vladimir Volodko

+ 44 (0) 20 7907 8500

Strand Hanson (nominated adviser to Team) Richard Johnson / James Spinney / Harry Marshall

+ 44 (0) 20 7409 3494

Novella Communications (financial PR to Team) Tim Robertson / Safia Colebrook

+44 (0) 20 3151 7008team@novella-comms.com

W.H. Ireland Group plc Phillip Wale (Chief Executive Officer)Simon Jackson (Chief Finance Officer)

+ 44 (0) 20 7220 1666

Shore Capital (Financial Adviser and Rule 3 Adviser to WH Ireland) David Coaten / Oliver Jackson / Ansh Batura

+ 44 (0) 207 408 4090

Zeus Capital Limited (nominated adviser and broker to WH Ireland) Katy Mitchell / Harry Ansell / James Bavister

+ 44 (0) 203 829 5000

MHP (WH Ireland's PR advisers) Reg Hoare

+ 44 (0) 7831 406117

Shore Capital and Corporate Limited and Shore Capital Stockbrokers Limited (either individually or collectively "Shore Capital") which are authorised and regulated by the Financial Conduct Authority in the United Kingdom, are acting exclusively for WH Ireland and for no-one else in connection with the Acquisition and will not be responsible to anyone other than WH Ireland, for providing the protections afforded to clients of Shore Capital, or for providing advice in relation to the Acquisition or any other matter referred to herein. Neither Shore Capital and Corporate Limited nor Shore Capital Stockbrokers Limited, nor any of their subsidiaries or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Shore Capital in connection with this announcement, any statement contained herein or otherwise.

H&P Advisory Limited ("Hannam & Partners") which, in the United Kingdom, is authorised and regulated by the Financial Conduct Authority, is acting exclusively for Team and no one else in connection with the Acquisition and will not be responsible to anyone other than Team for providing the protections afforded to clients of Hannam & Partners nor for providing advice in relation to the Acquisition or any other matter or arrangement referred to in this Announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOASEWFLLEMSELD
Date   Source Headline
23rd Dec 202410:45 amRNSConvertible Loan Note and Notice of EGM
12th Dec 20248:35 amRNSCompletion of WRAP retail offer
9th Dec 20244:45 pmRNSExtension of Retail Offer Closing Date
5th Dec 20247:00 amRNSConvertible Loan Notes
3rd Dec 20244:34 pmRNSWRAP retail offer
3rd Dec 20244:30 pmRNSPlacing Subscription and Wrap Retail Offer
18th Nov 202411:25 amRNSTrading Statement
7th Nov 20247:00 amRNSHolding(s) in Company - New Strategic Shareholder
25th Oct 20243:30 pmRNSUpdate on HBFS acquisition
23rd Aug 20242:15 pmRNSHolding(s) in Company
26th Jul 20244:45 pmRNSHolding(s) in Company
11th Jul 20247:00 amRNSInvestor Presentation
27th Jun 20249:25 amRNSIssue of Equity
27th Jun 20247:00 amRNSHalf-year Report
7th May 20243:30 pmRNSConvertible Loan Note
30th Apr 20243:30 pmRNSHolding(s) in Company
17th Apr 20244:00 pmRNSResult of AGM and Issue of New Shares
12th Apr 20247:00 amRNSResult of WRAP Retail Offer
9th Apr 20247:00 amRNSNotice of Investor Presentation
5th Apr 202411:15 amRNSDirector/PDMR Shareholding
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:25 pmRNSResult of Subscription
28th Mar 20247:02 amRNSWrap Retail Offer
28th Mar 20247:01 amRNSPlacing, Subscription and Wrap Retail Offer
28th Mar 20247:00 amRNSFinal Results
29th Feb 20244:00 pmRNSChange of Adviser
27th Dec 20237:00 amRNSAcquisition of HBFS
12th Dec 20237:00 amRNSAcquisition of Neba Businesses
9th Nov 202312:20 pmRNSHolding(s) in Company
8th Nov 20239:50 amRNSHolding(s) in Company
7th Nov 20234:40 pmRNSHolding(s) in Company
27th Oct 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Sep 20237:00 amRNSLoan Note
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20237:02 amRNSAcquisition
1st Jun 20237:01 amRNSAcquisition
1st Jun 20237:00 amRNSHalf-year Report
31st Jan 20234:00 pmRNSResult of AGM
12th Jan 202311:30 amRNSNotice of AGM
11th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSFinal Results
26th Oct 20222:18 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSChange of Adviser
9th Aug 20224:45 pmRNSDirector/PDMR Shareholding
8th Aug 20229:03 amRNSAcquisition
4th Aug 20223:35 pmRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSCompletion of Acquisition
1st Jul 20221:45 pmRNSDirector/PDMR Shareholding
23rd Jun 20221:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20224:10 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.